Article Versions Notes

Hsu F-T, Liu Y-C, Tsai C-L, Yueh P-F, Chang C-H, Lan K-L. Preclinical Evaluation of Recombinant Human IL15 Protein Fused with Albumin Binding Domain on Anti-PD-L1 Immunotherapy Efficiency and Anti-Tumor Immunity in Colon Cancer and Melanoma. Cancers. 2021; 13(8):1789. https://doi.org/10.3390/cancers13081789

Hsu, Fei-Ting, Yu-Chang Liu, Chang-Liang Tsai, Po-Fu Yueh, Chih-Hsien Chang, and Keng-Li Lan. 2021. "Preclinical Evaluation of Recombinant Human IL15 Protein Fused with Albumin Binding Domain on Anti-PD-L1 Immunotherapy Efficiency and Anti-Tumor Immunity in Colon Cancer and Melanoma" Cancers 13, no. 8: 1789. https://doi.org/10.3390/cancers13081789

Hsu, F. -T., Liu, Y. -C., Tsai, C. -L., Yueh, P. -F., Chang, C. -H., & Lan, K. -L. (2021). Preclinical Evaluation of Recombinant Human IL15 Protein Fused with Albumin Binding Domain on Anti-PD-L1 Immunotherapy Efficiency and Anti-Tumor Immunity in Colon Cancer and Melanoma. Cancers, 13(8), 1789. https://doi.org/10.3390/cancers13081789